Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASTERN: Low-dose Aspirin for Gastric Cancer Prevention
NCT04214990Phase 3Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Feb 2020
- Primary completion
- Mar 2031
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastric cancer (GC) comparing Aspirin with Placebo (2 arms). Primary endpoint: Incidence of gastric cancer at 5 years. Started Feb 2020; status: recruiting.
02
Drugs
aspirin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04214990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04214990.